Company TapImmune Inc. OTC Bulletin Board
Equities
TPIV
US8760334081
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 16/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/10/19 |
Chief Tech/Sci/R&D Officer | 51 | 22/10/18 | |
Chief Administrative Officer | - | 31/08/15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 31/12/20 |
Nadia Agopyan
LAW | General Counsel | 62 | 14/08/19 |
General Counsel | 67 | 22/10/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 16/10/18 |
Steven Elms
BRD | Director/Board Member | 60 | 05/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 07/12/21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 16/10/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,919,095 | 7,830,643 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
+10.74% | 25.92B | |
-13.50% | 26.03B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B | |
-12.61% | 10.64B |